The small-molecule FPR2/ALX agonist, quin-C1, increased the viability of human SH-SY5Y neuroblastoma via MTT assay but not NRU and can induce neurite outgrowth Sheree Smith,Nathaniel Milton,Andrew PatersonBRITISH JOURNAL OF PHARMACOLOGY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
